{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:45Z","timestamp":1790400645213,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Center for Drug Design at the University of Minnesota"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.antiviral.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:59:45Z","timestamp":1517903985000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Metal-chelating 3-hydroxypyrimidine-2,4-diones inhibit human cytomegalovirus pUL89 endonuclease activity and virus replication"],"prefix":"10.1016","volume":"152","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-6509","authenticated-orcid":false,"given":"Robert J.","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.01.015_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152611797636640","article-title":"Antiviral treatment of cytomegalovirus infection","volume":"11","author":"Ahmed","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2018.01.015_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tim.2011.09.001","article-title":"Herpes simplex virus capsid assembly and DNA packaging: a present and future antiviral drug target","volume":"19","author":"Baines","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.humimm.2004.02.007","article-title":"Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs","volume":"65","author":"Baldanti","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib4","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1128\/JVI.75.19.9077-9086.2001","article-title":"A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products","volume":"75","author":"Buerger","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib5","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1128\/JVI.79.12.7792-7802.2005","article-title":"Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication","volume":"79","author":"Cantrell","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/135965350701200209","article-title":"New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc","volume":"12","author":"Champier","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.01.015_bib7","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01325-17","article-title":"Comparison of cytomegalovirus terminase gene mutations selected after exposure to three distinct inhibitor compounds","volume":"61","author":"Chou","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.10.019","article-title":"A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance","volume":"148","author":"Chou","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2018.01.015_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nprot.2011.330","article-title":"A time-of-drug addition approach to target identification of antiviral compounds","volume":"6","author":"Daelemans","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2018.01.015_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jviromet.2008.03.025","article-title":"Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus","volume":"151","author":"Dal Pozzo","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.01.015_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/AAC.49.3.873-883.2005","article-title":"Human cytomegalovirus resistance to antiviral drugs","volume":"49","author":"Gilbert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/AAC.01794-13","article-title":"Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure","volume":"58","author":"Goldner","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib14","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib15","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/acs.jmedchem.6b00465","article-title":"Design, synthesis, and biological evaluations of hydroxypyridonecarboxylic acids as inhibitors of HIV reverse transcriptase associated RNase H","volume":"59","author":"Kankanala","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.01.015_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.01.015_bib18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib19","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.01.015_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.biochem.5b01254","article-title":"Characterization of the C-Terminal nuclease domain of herpes simplex virus pUL15 as a target of nucleotidyltransferase inhibitors","volume":"55","author":"Masaoka","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2018.01.015_bib21","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1073\/pnas.1007144107","article-title":"Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain","volume":"107","author":"Nadal","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.01.015_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02384-16","article-title":"Mutual interplay between the human cytomegalovirus terminase subunits pUL51, pUL56, and pUL89 promotes terminase complex formation","volume":"91","author":"Neuber","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01044-17","article-title":"Drug susceptibility and replicative capacity of multidrug-resistant recombinant human cytomegalovirus harboring mutations in UL56 and UL54 genes","volume":"61","author":"Piret","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2018.01.015_bib24","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.01.015_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/48.6.757","article-title":"Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action","volume":"48","author":"Reefschlaeger","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib26","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1128\/JVI.73.10.8338-8348.1999","article-title":"Proteolytic cleavage of the amino terminus of the U(L)15 gene product of herpes simplex virus type 1 is coupled with maturation of viral DNA into unit-length genomes","volume":"73","author":"Salmon","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/nar\/30.7.1695","article-title":"The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure","volume":"30","author":"Scheffczik","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.01.015_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sbi.2009.12.006","article-title":"Genome packaging in viruses","volume":"20","author":"Sun","year":"2010","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib29","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.5b01879","article-title":"3-Hydroxypyrimidine-2,4-diones as selective active site inhibitors of HIV reverse transcriptase-associated RNase H: Design, synthesis, and biochemical evaluations","volume":"59","author":"Tang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.01.015_bib30","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.bmcl.2011.02.069","article-title":"6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase","volume":"21","author":"Tang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2018.01.015_bib31","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1021\/jm1014378","article-title":"3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase","volume":"54","author":"Tang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.01.015_bib32","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1128\/AAC.03875-14","article-title":"Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication","volume":"58","author":"Tavis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.01.015_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JVI.72.1.717-725.1998","article-title":"Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product","volume":"72","author":"Underwood","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm501132s","article-title":"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-Hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities","volume":"58","author":"Vernekar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.01.015_bib35","article-title":"Inhibition of human cytomegalovirus pUL89 terminase subunit blocks virus replication and genome cleavage","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.01.015_bib36","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/acs.jmedchem.6b00040","article-title":"3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides potently inhibit HIV-1 integrase and RNase H","volume":"59","author":"Wu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.01.015_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01318-14","article-title":"HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses","volume":"5","author":"Yan","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2018.01.015_bib38","doi-asserted-by":"crossref","first-page":"11003","DOI":"10.1093\/nar\/gkv1018","article-title":"Two distinct modes of metal ion binding in the nuclease active site of a viral DNA-packaging terminase: insight into the two-metal-ion catalytic mechanism","volume":"43","author":"Zhao","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T23:30:17Z","timestamp":1660433417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217306927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"alternative-id":["S0166354217306927"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.01.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metal-chelating 3-hydroxypyrimidine-2,4-diones inhibit human cytomegalovirus pUL89 endonuclease activity and virus replication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}